Targeted mitochondrial therapy using MitoQ shows equivalent renoprotection to angiotensin converting enzyme inhibition but no combined synergy in diabetes.
Ward MS, Flemming NB, Gallo LA, Fotheringham AK, McCarthy DA, Zhuang A, Tang PH, Borg DJ, Shaw H, Harvie B, Briskey DR, Roberts LA, Plan MR, Murphy MP, Hodson MP, Forbes JM.
Ward MS, et al. Among authors: harvie b.
Sci Rep. 2017 Nov 9;7(1):15190. doi: 10.1038/s41598-017-15589-x.
Sci Rep. 2017.
PMID: 29123192
Free PMC article.